During this phase, HIF1A/HIF-1α, which remains stably expressed, enhances tumor-suppressive metabolic reprogramming by activating BNIP3-dependent selective mitophagy, which in turn inhibits glycolysis [70]. The gene discussed is HIF1A; the disease is neoplasm.